Skip to main content
Fig. 2 | Hereditas

Fig. 2

From: Defining muscle-invasive bladder cancer immunotypes by introducing tumor mutation burden, CD8+ T cells, and molecular subtypes

Fig. 2

Molecular and clinical characterization of MIBC immunotypes. a The heatmap shows the distribution of basal, luminal, immune checkpoints, tumor-infiltrating immune cell-related biomarkers in immunotypes. b The K-M plot of patients based on TCGA dataset indicates that patients in immunotype A behaved a better overall survival profile than other immunotypes. c The Kaplan-Meier plot of patients based on the IMvigor210 dataset confirms that patients in immunotype A conferred the best overall survival profiles. d The bar graph depicts the response rate of MIBC patients to immunotherapy in the immunotypes based on the IMvigor210 dataset

Back to article page